ATE144558T1 - Oligonukleotiden-sequenzen zur amplifizierung von hiv-2 und siv retrovirusgenomen, ihre verwendung zur in-vitro-diagnostik von durch diese viren verursachten infektionen - Google Patents

Oligonukleotiden-sequenzen zur amplifizierung von hiv-2 und siv retrovirusgenomen, ihre verwendung zur in-vitro-diagnostik von durch diese viren verursachten infektionen

Info

Publication number
ATE144558T1
ATE144558T1 AT90401521T AT90401521T ATE144558T1 AT E144558 T1 ATE144558 T1 AT E144558T1 AT 90401521 T AT90401521 T AT 90401521T AT 90401521 T AT90401521 T AT 90401521T AT E144558 T1 ATE144558 T1 AT E144558T1
Authority
AT
Austria
Prior art keywords
viruses
oligonucleotide sequences
infections caused
vitro diagnostics
amplifying hiv
Prior art date
Application number
AT90401521T
Other languages
English (en)
Inventor
Pierre Sonigo
Christian Brechot
Valerie Courgnaud
Original Assignee
Pasteur Institut
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Inst Nat Sante Rech Med filed Critical Pasteur Institut
Application granted granted Critical
Publication of ATE144558T1 publication Critical patent/ATE144558T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • AIDS & HIV (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT90401521T 1989-06-02 1990-06-05 Oligonukleotiden-sequenzen zur amplifizierung von hiv-2 und siv retrovirusgenomen, ihre verwendung zur in-vitro-diagnostik von durch diese viren verursachten infektionen ATE144558T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8907355A FR2647810B1 (fr) 1989-06-02 1989-06-02 Amorces oligonucleotidiques pour l'amplification du genome des retrovirus du type hiv-2 et siv, et leurs applications au diagnostic in vitro des infections dues a ces virus

Publications (1)

Publication Number Publication Date
ATE144558T1 true ATE144558T1 (de) 1996-11-15

Family

ID=9382332

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90401521T ATE144558T1 (de) 1989-06-02 1990-06-05 Oligonukleotiden-sequenzen zur amplifizierung von hiv-2 und siv retrovirusgenomen, ihre verwendung zur in-vitro-diagnostik von durch diese viren verursachten infektionen

Country Status (11)

Country Link
US (1) US6020123A (de)
EP (1) EP0404625B1 (de)
JP (1) JPH04505558A (de)
AT (1) ATE144558T1 (de)
CA (3) CA2341946C (de)
DE (1) DE69028951T2 (de)
DK (1) DK0404625T3 (de)
ES (1) ES2095241T3 (de)
FR (1) FR2647810B1 (de)
GR (1) GR3022248T3 (de)
WO (1) WO1990015158A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2677039B1 (fr) * 1991-05-31 1994-09-09 Cis Bio Int Oligonucleotides, utilisables comme reactifs pour la detection in vitro des infections a retrovirus de type hiv et procede de detection de retrovirus de type hiv.
CN102134609A (zh) 1994-10-20 2011-07-27 巴斯德研究所 Hiv-1 o组(或亚组)逆转录病毒抗原的核苷酸序列
FR2731225B1 (fr) * 1995-03-03 2003-10-31 Pasteur Institut Peptides de glycoproteine transmembranaire d'enveloppe et de proteine de capside du retrovirus humain du type hiv-1 et peptides presentant avec eux une parente immunologique
US5962665A (en) * 1997-06-16 1999-10-05 Abbott Laboratories Nucleic acid primers and probes for detecting HIV-1 and HIV-2
US6001558A (en) * 1997-06-25 1999-12-14 Ortho Clinical Diagnostics, Inc. Amplification and detection of HIV-1 and/or HIV 2
DE60132924T2 (de) 2000-10-23 2009-03-05 Gen-Probe Inc., San Diego Zusammensetzungen und methoden zur detektion von humanem immundefizienz virus 2 (hiv-2)
WO2003062377A2 (en) * 2002-01-17 2003-07-31 The Uab Research Foundation COMPLETE GENOME SEQUENCE OF SIVcpzTAN1
CA2547750C (en) 2003-12-19 2014-04-08 Gen-Probe Incorporated Compositions, methods and kits for detecting the nucleic acids of hiv-1 and hiv-2
US8747862B2 (en) 2008-11-14 2014-06-10 Tulane University Health Sciences Center Pathogenic west african human immunodeficiency virus type 2 (HIV-2) group F isolate
CA2793959C (en) 2010-03-25 2019-06-04 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
CA2832109C (en) 2011-06-10 2021-07-06 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
AU2012216792A1 (en) 2011-09-12 2013-03-28 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies
EP2679596B1 (de) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 Env-proteinvariante
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
EP2873423B1 (de) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE64006B1 (en) * 1984-10-18 1995-06-28 Pasteur Institut Antigens particulary envelope antigens of the virus of lymphadenopathies and of the acquired immune-deficiency syndrome and virus process for producing virus envelope antigens use of said antigens in the preparation of immunogenic compositions or for the diagnosis of the presence of antibodies against this virus
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
AU606043B2 (en) * 1985-03-28 1991-01-31 F. Hoffmann-La Roche Ag Detection of viruses by amplification and hybridization
ES2150897T3 (es) * 1986-01-22 2000-12-16 Pasteur Institut Procedimiento de fabricacion recombinante de las proteinas derivadas de hiv-2 y cultivo celular que expresa proteinas de hiv-2.
US4839288A (en) * 1986-01-22 1989-06-13 Institut Pasteur Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes
US4806463A (en) * 1986-05-23 1989-02-21 Worcester Foundation For Experimental Biology Inhibition of HTLV-III by exogenous oligonucleotides
US5030714A (en) * 1986-06-23 1991-07-09 Institut Pasteur Variant of LAV viruses
ATE88762T1 (de) * 1986-08-11 1993-05-15 Siska Diagnostics Inc Methoden und zusammensetzungen fuer tests mit nukleinsaeuresonden.
US5079351A (en) * 1986-11-26 1992-01-07 Cetus Corporation Oligonucleotides and kits for detection of htlvi and htlvii viruses by hybridization
ATE154808T1 (de) * 1987-01-16 1997-07-15 Pasteur Institut Peptide mit den immunologischen eigenschaften von hiv-2

Also Published As

Publication number Publication date
EP0404625A2 (de) 1990-12-27
GR3022248T3 (en) 1997-04-30
CA2055612C (fr) 2001-07-31
FR2647810B1 (fr) 1994-07-22
WO1990015158A1 (fr) 1990-12-13
CA2592555A1 (fr) 1990-12-13
JPH04505558A (ja) 1992-10-01
ES2095241T3 (es) 1997-02-16
EP0404625A3 (de) 1991-01-16
DK0404625T3 (da) 1997-03-10
DE69028951D1 (de) 1996-11-28
CA2341946A1 (fr) 1990-12-13
CA2592555C (fr) 2010-01-05
EP0404625B1 (de) 1996-10-23
US6020123A (en) 2000-02-01
CA2055612A1 (fr) 1990-12-03
CA2341946C (fr) 2007-10-23
DE69028951T2 (de) 1997-05-07
FR2647810A1 (fr) 1990-12-07

Similar Documents

Publication Publication Date Title
WO1990015066A3 (fr) Sequences nucleotidiques issues du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications notamment pour l'amplification des genomes de ces retrovirus et pour le diagnostic in vitro des infections dues a ces virus
ATE144558T1 (de) Oligonukleotiden-sequenzen zur amplifizierung von hiv-2 und siv retrovirusgenomen, ihre verwendung zur in-vitro-diagnostik von durch diese viren verursachten infektionen
DE69833160D1 (de) Amplifizierung und Detektion von HIV-1 und/oder HIV-2
ES2194029T3 (es) Variantes del virus hiv-2.
ATE120234T1 (de) Hiv-3-retrovirus und seine verwendung.
ATE60800T1 (de) Klonierte dns-sequenzen, hybridisierbar mit genom-rns vom ''lymphadenopathy-associated virus (lav)''.
GR1000489B (el) Αλληλουχιες dna,μορια ανασυνδιασμενου dna και μεθοδοι για την παραγωγη διαλυτων τ4 πρωτεινων.
ATE106748T1 (de) Vakzine zum schutz vor hiv-virusinfektionen, verfahren zu ihrer herstellung und ihre verwendung als diagnostikum und immuntherapeutikum.
ATE386821T1 (de) Zusammensetzungen und methoden zur detektion von humanem immundefizienz virus 2 (hiv-2)
DK0831899T3 (da) Rekombinant koppevirus-calicivirus-præparater og anvendelser
ATE121779T1 (de) Nichtzurückschlagende rns-viren.
ATE212056T1 (de) Methoden zur herstellung von rna viren aus cdna
ATE337404T1 (de) Zur verleihung viraler resistenz an pflanzen geeignetes polyribozym und dieses polyribozym produzierende resistente pflanzen
Centers for Disease Control and Prevention (CDC Nonhuman primate spumavirus infections among persons with occupational exposure--United States, 1996
FR2652091B1 (fr) Sequences nucleotidiques issues du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications notamment pour l'amplification des genomes de ces retrovirus et pour le diagnostic in-vitro des infections dues a ces virus.
DE60035680D1 (de) Komplette gensequenz des esel-leukozyten-impfstoffstammes des equinen infektiösen anemievirus und ihre anwendung
FI893346A0 (fi) Icke-reverterande rna-virus.
ATE198602T1 (de) Makrocyclische difluorostatonderivate als antivirale mittel
RU93050541A (ru) Соединения, выделенные из растений семейства и их производные, способ их получения и применение

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time